Track Ventyx Biosciences's accounts payable ($990K) with charts, peers, and YoY trends.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (September 2025), VTYX shows a accounts payable of $990K. That compares with $2.3M in the prior-year period — down 56.6% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, VTYX's accounts payable is now $990K (was $2.3M) — a 56.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Ventyx Biosciences is outperforming or lagging.
Tracking VTYX's accounts payable over time shows whether Ventyx Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $990K That compares with $2.3M in the prior-year period — down 56.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this accounts payable page, Stockcircle has Ventyx Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $990K) with ownership activity and broader fundamentals.